157 related articles for article (PubMed ID: 874746)
1. Diffusion model for drug release from suspensions I: theoretical considerations.
Ayres JW; Lindstrom FT
J Pharm Sci; 1977 May; 66(5):654-62. PubMed ID: 874746
[TBL] [Abstract][Full Text] [Related]
2. Diffusion model for drug release from suspensions II: release to a perfect sink.
Lindstrom FT; Ayres JW
J Pharm Sci; 1977 May; 66(5):662-8. PubMed ID: 874747
[TBL] [Abstract][Full Text] [Related]
3. Release of drugs from ointment bases II: In vitro release of benzocaine from suspension-type aqueous gels.
Bottari F; Di Colo G; Nannipieri E; Saettone MF; Serafini MF
J Pharm Sci; 1977 Jul; 66(7):926-31. PubMed ID: 886452
[TBL] [Abstract][Full Text] [Related]
4. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
George K
Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
[TBL] [Abstract][Full Text] [Related]
5. A diffusion-diffusion model for percutaneous drug absorption.
Kubota K; Ishizaki T
J Pharmacokinet Biopharm; 1986 Aug; 14(4):409-39. PubMed ID: 3772740
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous absorption.
Brisson P
Can Med Assoc J; 1974 May; 110(10):1182-5. PubMed ID: 4597976
[TBL] [Abstract][Full Text] [Related]
7. A general model of coupled drug release and tissue absorption for drug delivery devices.
McGinty S; Pontrelli G
J Control Release; 2015 Nov; 217():327-36. PubMed ID: 26390809
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical interpretation of the pharmacokinetics of percutaneous absorption.
Guy RH; Hadgraft J
J Pharmacokinet Biopharm; 1983 Apr; 11(2):189-203. PubMed ID: 6886974
[TBL] [Abstract][Full Text] [Related]
9. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
10. Application of numerical methods for diffusion-based modeling of skin permeation.
Frasch HF; Barbero AM
Adv Drug Deliv Rev; 2013 Feb; 65(2):208-20. PubMed ID: 22261307
[TBL] [Abstract][Full Text] [Related]
11. Experimental determination of the diffusion boundary layer width of micron and submicron particles.
Galli C
Int J Pharm; 2006 Apr; 313(1-2):114-22. PubMed ID: 16529883
[TBL] [Abstract][Full Text] [Related]
12. A theoretical consideration of percutaneous drug absorption.
Kubota K; Ishizaki T
J Pharmacokinet Biopharm; 1985 Feb; 13(1):55-72. PubMed ID: 4020622
[TBL] [Abstract][Full Text] [Related]
13. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
Gratieri T; Kalia YN
Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of dissolution and diffusion-controlled drug release systems.
Simon L; Bolisetty P; Erazo MN
Curr Drug Deliv; 2011 Mar; 8(2):144-51. PubMed ID: 21235474
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
16. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.
Siepmann J; Siepmann F; Florence AT
Int J Pharm; 2006 May; 314(2):101-19. PubMed ID: 16647231
[TBL] [Abstract][Full Text] [Related]
17. Vehicle effects in percutaneous absorption.
Idson B
Drug Metab Rev; 1983; 14(2):207-22. PubMed ID: 6341025
[No Abstract] [Full Text] [Related]
18. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
Sun DD; Lee PI
Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
[TBL] [Abstract][Full Text] [Related]
19. Controlling release from encapsulated drug-loaded devices: insights from modeling the dissolution front propagation.
Jain A; King D; Pontrelli G; McGinty S
J Control Release; 2023 Aug; 360():225-235. PubMed ID: 37328006
[TBL] [Abstract][Full Text] [Related]
20. Mixing-tank model for predicting dissolution rate control or oral absorption.
Dressman JB; Fleisher D
J Pharm Sci; 1986 Feb; 75(2):109-16. PubMed ID: 3958917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
